Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Utikal

Showing results (101-110 of 276) with videos related to

Pageof 28
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
8. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 21.01.2022Frank Meiß, Thomas K Eigentler, Margit Huber, et al.
Journal of Cutaneous Pathology|September 16, 2006
Cutaneous leiomyosarcoma with myxoid alteration arising in a setting of multiple cutaneous smooth muscle neoplasmsJochen Utikal, Georg Haus, Nina Poenitz, et al.
Cellular Immunology|December 9, 2020
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapyRebekka Weber, Christopher Groth, Samantha Lasser, et al.
Oncoimmunology|August 18, 2023
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCsAlisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, et al.
International Journal of Molecular Sciences|September 4, 2020
Myeloid Cell Modulation by Tumor-Derived Extracellular VesiclesIhor Arkhypov, Samantha Lasser, Vera Petrova, et al.
Stem Cells and Development|February 25, 2016
Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage FormationSolvig Diederichs, Jessica Gabler, Jennifer Autenrieth, et al.
Journal of Translational Medicine|October 9, 2019
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithmNeta Tsur, Yuri Kogan, Evgenia Avizov-Khodak, et al.
Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.
Molecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.
Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.
Pageof 28

Showing results (101-110 of 276) with videos related to

Sort By:
Pageof 28
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2022
8. Virtuelles Netzwerktreffen der zertifizierten Hautkrebszentren 21.01.2022Frank Meiß, Thomas K Eigentler, Margit Huber, et al.
Journal of Cutaneous Pathology|September 16, 2006
Cutaneous leiomyosarcoma with myxoid alteration arising in a setting of multiple cutaneous smooth muscle neoplasmsJochen Utikal, Georg Haus, Nina Poenitz, et al.
Cellular Immunology|December 9, 2020
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapyRebekka Weber, Christopher Groth, Samantha Lasser, et al.
Oncoimmunology|August 18, 2023
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCsAlisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, et al.
International Journal of Molecular Sciences|September 4, 2020
Myeloid Cell Modulation by Tumor-Derived Extracellular VesiclesIhor Arkhypov, Samantha Lasser, Vera Petrova, et al.
Stem Cells and Development|February 25, 2016
Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage FormationSolvig Diederichs, Jessica Gabler, Jennifer Autenrieth, et al.
Journal of Translational Medicine|October 9, 2019
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithmNeta Tsur, Yuri Kogan, Evgenia Avizov-Khodak, et al.
Molecular Therapy Oncolytics|July 9, 2020
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant MelanomaAniello Federico, Tamara Steinfass, Lionel Larribère, et al.
Molecular Oncology|October 4, 2025
The neural crest-associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapyNina Wang, Qian Sun, Daniel Novak, et al.
Cancers|February 25, 2022
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6Marlene Vierthaler, Qian Sun, Yiman Wang, et al.
Pageof 28